Even in the case of uncomplicated infections, the body prepares itself early on for the possibility of a more severe course.

A team from the Max Planck Research Group for Systems Immunology at the University of Würzburg has identified a previously ...

Both studies, which are reporting the results of early-stage clinical trials, show that the interventions were safe, and that ...

image: QRICH1 fine-tunes the signaling of T cell receptors by regulating CARD11 view more Credit: Nicole M. Carter In a study ...

Physician-scientists at Memorial Sloan Kettering Cancer Center (MSK) recently published two papers that advance the science of addressing critical issues with CAR T cell therapy in patients with ...

Chimeric antigen receptor t-cell, or CAR-T therapy, uses a person’s own immune cells to attack cancer. Dean Berhaupt is the first person in the Capital Region to receive the therapy as he battles ...

T cells are white blood cells that are important for adaptive immunity. They have unique cell surface receptors that are generated by randomly assorting genes. These receptors allow T cells to ...

A bold funding initiative aims to help scientists predict a T cell’s target antigens, with implications far beyond cancer therapy.

UAE's Burjeel Holdings has joined forces with US-based non-profit Caring Cross to locally manufacture CAR-T (Chimeric Antigen ...

Dean Berhaupt has become the first patient to receive CAR T-cell therapy in Albany, marking a significant milestone for ...

CAR T-cell therapy has significantly improved outcomes for B-ALL patients, but relapse still occurs in over 50% of cases, leaving many with limited treatment options. Ongoing research aims to ...

Even in the case of uncomplicated infections, the body prepares itself early on for the possibility of a more severe course. A research team has now uncovered this mechanism. The scientists showed ...